CD4(+) cell count increase predicts clinical benefits in patients with advanced HIV disease and persistent viremia after 1 year of combination antiretroviral therapy.
about
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in NigeriaCanadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS PatientsTreatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure.Cost-effectiveness of tipranavir in treatment-experienced HIV patients in the United States.
P2860
CD4(+) cell count increase predicts clinical benefits in patients with advanced HIV disease and persistent viremia after 1 year of combination antiretroviral therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
CD4(+) cell count increase pre ...... nation antiretroviral therapy.
@en
type
label
CD4(+) cell count increase pre ...... nation antiretroviral therapy.
@en
prefLabel
CD4(+) cell count increase pre ...... nation antiretroviral therapy.
@en
P2093
P356
P1476
CD4(+) cell count increase pre ...... ination antiretroviral therapy
@en
P2093
Canada HIV Trials Network
Christopher M Mullin
George Perez
James D Neaton
Mona R Loutfy
Terry Beirn Community Programs for Clinical Research on AIDS
P304
P356
10.1086/466537
P407
P50
P577
2005-09-09T00:00:00Z